<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>HYPOTHESIS: Screening for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> has focused on identifying <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (BE) in patients with severe, long-standing symptoms of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Unfortunately, 95% of patients who develop esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> are unaware of the presence of BE before their <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis, which means they never had been selected for screening </plain></SENT>
<SENT sid="2" pm="."><plain>One possible explanation is that no correlation exists between the severity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="3" pm="."><plain>We hypothesize that severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms are not associated with an increase in the prevalence of BE, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in patients undergoing primary endoscopic screening </plain></SENT>
<SENT sid="4" pm="."><plain>DESIGN: Cross-sectional study </plain></SENT>
<SENT sid="5" pm="."><plain>SETTING: University hospital </plain></SENT>
<SENT sid="6" pm="."><plain>PATIENTS: A total of 769 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>INTERVENTIONS: Primary screening endoscopy performed from November 1, 2004, through June 7, 2007 </plain></SENT>
<SENT sid="8" pm="."><plain>MAIN OUTCOMES MEASURES: Symptom severity, <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> therapy, and esophageal adenocarcinogenesis (ie, BE, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Endoscopy revealed adenocarcinogenesis in 122 patients </plain></SENT>
<SENT sid="10" pm="."><plain>An increasing number of severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms correlated positively with endoscopic findings of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (odds ratio, 1.05; 95% confidence interval, 1.01-1.09) </plain></SENT>
<SENT sid="11" pm="."><plain>Conversely, an increasing number of severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms were associated with decreased odds of adenocarcinogenesis (odds ratio, 0.94; 95% confidence interval, 0.89-0.98) </plain></SENT>
<SENT sid="12" pm="."><plain>Patients taking <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> were 61.3% and 81.5% more likely to have adenocarcinogenesis if they reported no severe typical or atypical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms, respectively, compared with patients taking <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi>, who reported that <z:hpo ids='HP_0000001'>all</z:hpo> symptoms were severe </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Medically treated patients with mild or absent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms have significantly higher odds of adenocarcinogenesis compared with medically treated patients with severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms </plain></SENT>
<SENT sid="14" pm="."><plain>This finding may explain the failure of the current screening paradigm in which the threshold for primary endoscopic examination is based on symptom severity </plain></SENT>
</text></document>